V Limmroth
6. Epilepsie
Tettenborn B, Limmroth V, Maschke M. 6. Epilepsie. In: Aktuelle Entwicklung in der Neurologie. 2014. pp. 141-154.
Jan 1, 20146. Epilepsie
Jan 1, 2014
Tettenborn Barbara, Limmroth V, Maschke M
Neues aus der Epileptologie
Tettenborn B, Limmroth V, Maschke M. Neues aus der Epileptologie. In: Aktuelle Entwicklung in der Neurologie. 2013. pp. 115-122.
Jan 1, 2013Neues aus der Epileptologie
Jan 1, 2013
Tettenborn Barbara, Limmroth V, Maschke M
Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries
Tettenborn B, Putzki N, Yaldizli O, Mäurer M, Cursiefen S, Kuckert S, Maschke M, Limmroth V. Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries. Eur J Neurol 2010; 17 (1):31-7.
Jun 7, 2010Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries
Jun 7, 2010Eur J Neurol 2010; 17 (1):31-7
Tettenborn Barbara, Putzki Norman, Yaldizli Oezguer, Mäurer M, Cursiefen S, Kuckert S, Maschke M, Limmroth V
Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries
Putzki N, Yaldizli O, Mäurer M, Cursiefen S, Kuckert S, Klawe C, Maschke M, Tettenborn B, Limmroth V. Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries. European journal of neurology : the official journal of the European Federation of Neurological Societies 2009
Jul 9, 2009Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries
Jul 9, 2009European journal of neurology : the official journal of the European Federation of Neurological Societies 2009
Putzki Norman, Yaldizli O, Mäurer M, Cursiefen S, Kuckert S, Klawe C, Maschke M, Tettenborn Barbara, Limmroth V
Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis
Putzki N, Kollia K, Woods S, Igwe E, Diener H, Limmroth V. Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis. European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:424-6.
Mar 1, 2009Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis
Mar 1, 2009European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:424-6
Putzki Norman, Kollia K, Woods S, Igwe E, Diener H C, Limmroth V
Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis
Tettenborn B, Putzki N, Pfriem A, Limmroth V, Yaldizli O, Diener H, Katsarava Z. Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol 2009; 16(2):262-7.
Feb 7, 2009Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis
Feb 7, 2009Eur J Neurol 2009; 16(2):262-7
Tettenborn Barbara, Putzki Norman, Pfriem A, Limmroth V, Yaldizli Oezguer, Diener HC, Katsarava Z
Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis
Putzki N, Pfriem A, Limmroth V, Yaldizli O, Tettenborn B, Diener H, Katsarava Z. Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:262-7.
Feb 1, 2009Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis
Feb 1, 2009European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:262-7
Putzki Norman, Pfriem A, Limmroth V, Yaldizli O, Tettenborn B, Diener H C, Katsarava Z
Relapsing neuromyelitis optica responsive to glatiramer acetate treatment
Gartzen K, Limmroth V, Putzki N. Relapsing neuromyelitis optica responsive to glatiramer acetate treatment. European journal of neurology : the official journal of the European Federation of Neurological Societies 2007; 14:e12-3.
Jun 1, 2007Relapsing neuromyelitis optica responsive to glatiramer acetate treatment
Jun 1, 2007European journal of neurology : the official journal of the European Federation of Neurological Societies 2007; 14:e12-3
Gartzen K, Limmroth V, Putzki Norman